About Hesperos
Hesperos is a company based in Orlando (United States) founded in 2015 by Michael Shuler and James J Hickman. Hesperos offers products and services including Human-on-a-Chip Platform, Organ Modules, and Disease Modeling Service. Hesperos operates in a competitive market with competitors including Emulate, CN Bio, AxoSim, Mimetas and Obatala Sciences, among others.
- Headquarter Orlando, United States
- Founders Michael Shuler, James J Hickman
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website hesperosinc.com
- Social LinkedIn X YouTube
- Legal Name Hesperos, Inc.
- Latest Funding Round$1.97M (USD), Grant
Aug 2021
- InvestorsHHS
& 1 more
Products & Services of Hesperos
Hesperos offers a comprehensive portfolio of products and services, including Human-on-a-Chip Platform, Organ Modules, and Disease Modeling Service.
In vitro system simulating human organ functions for drug efficacy and safety
Customizable components for disease modeling and therapeutic testing
Tools to replicate disease states for drug response analysis
Apps and channels of Hesperos
its YouTube channel Hesperos Inc has 50 subscribers and 15 videos.
Videos from Hesperos
The most watched videos on Hesperos's YouTube channel, Hesperos Inc (50 subscribers). Click a video to play it here.
More on Hesperos Inc.
Funding Insights of Hesperos
- Total Rounds 8
- Last Round Grant — $1.97M
- First Round $6.5M
(Sep 2016)
- Investors Count 2
All 8 funding rounds of Hesperos with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Hesperos
Hesperos has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and National Center for Advancing Translational Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Research is conducted to advance translational science for health solutions. | – | ncats.nih.gov | Rockville, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Hesperos
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Hesperos
13 people are tracked at Hesperos (4 in leadership, 9 in team).
| Name | Role | Group |
|---|---|---|
Michael Shuler | Co-Founder & CEO | Leadership |
James J Hickman | Co-Founder | Leadership |
James Kronauge | Chief Executive Officer | Leadership |
Nate Post | Director Of Business Operations | Leadership |
Isiah Mossiah | Research Associate 2 | Team |
Sam Richard | Research Associate 2 | Team |
Victoria Long | Principal Operations Analyst | Team |
Marcella Grillo | Surface Chemist Intern | Team |
Brianna Botlick | Research Associate II | Team |
Mridu Malik | Scientist I - Barrier Tissue Team Lead | Team |
Anyi Álvarez | Accountant I | Team |
Russell Emmons | Scientist - Multi-organ Team Lead | Team |
Kaveena Autar | Scientist III - Team Lead | Team |
Complete people profiles for Hesperos
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Hesperos
3 dated milestones of Hesperos across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Hesperos is founded.
- Funding First funding round of $6.5M.
- Funding Latest funding round, Grant, of $2.0M.
Competitors of Hesperos
Hesperos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emulate, CN Bio, AxoSim, Mimetas and Obatala Sciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| emulatebio.com | 2013 | Boston, United States | $204.49M | 93 | Developer of in vitro models for drug development | |
| cn-bio.com | 2009 | Cambridge, United Kingdom | $44.78M | 33 | Organ-on-a-chip platforms are developed for drug discovery applications. | |
| axosim.com | 2014 | New Orleans, United States | $6.78M | 27 | Nerve-on-a-chip technology is advanced by AxoSim for drug development improvement. | |
| mimetas.com | 2013 | Leiden, Netherlands | $28.9M | – | Microfluidics-based organ-on-a-chip models for drug evaluation are developed. | |
| obatalasciences.com | 2017 | New Orleans, United States | $3.54M | 10 | Provider of research enabling products and services to research centers | |
| nortisbio.com | 2007 | Woodinville, United States | $10.66M | 19 | Small human tissue segments are generated in microfluidic chips. | |
| netri.com | 2018 | Lyon, France | $8.89M | – | Microfluidic devices are developed for industrial applications and brain-on-a-chip models. | |
| mepsgen.com | 2019 | Seoul, South Korea | $29.26M | – | Developer of human organ model chips for pharmaceutical development | |
| tissuse.com | 2010 | Berlin, Germany | – | 31 | Multi-organ chip platform for tissue culture is developed. |
Detailed competitors of Hesperos
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Hesperos
The website of Hesperos (hesperosinc.com) receives about 6.1K visits a month.
- Monthly visits6.1K
▲ 31.5% vs previous month
Websites whose visitors overlap most with Hesperos. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| sanaramedtech.com | 100% | 13.4K | #1,747,373 | View details | |
| bendbioscience.com | 84% | 5.2K | #3,756,323 | View details |
Latest news on Hesperos
Complete news archive for Hesperos
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Hesperos
10 companies that operate in the same segment as Hesperos (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Hesperos
Hesperos was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Hesperos is headquartered in Orlando, United States. It is registered at Orlando, Florida, United States.
Michael Shuler is the current CEO of Hesperos. They have also founded this company.
Hesperos was founded in 2015 in Orlando, United States, focusing on biotechnology for preclinical drug testing. Organ-on-a-chip models, including heart-liver, neuromuscular junction, and multi-organ systems, are created using a pumpless platform with serum-free media. Integrated software for computer modeling and physiological monitoring is incorporated to support these systems. Operations center on advancing in vitro testing alternatives.
Hesperos offers Human-on-a-Chip Platform, Organ Modules, and Disease Modeling Service.
Hesperos has 2 investors. Key investors include HHS, and National Center for Advancing Translational Sciences.
Hesperos operates through Hesperos, Inc..